You searched for: adherence with dosing (Engelska - Kroatiska)

1 bottle with dosing syringe
1 boca u dozi rnu špricu

reinitiate treatment with nplate in accordance with dosing and administration recommendations.
ponovno započinjanje liječenja nplateom treba biti prema uputama o doziranju i primjeni.

clinical experience with dosing at intervals of less than 4 weeks or at doses above 600 mg or 8 mg/kg is limited.
klinička iskustva s doziranjem u intervalima kraćima od 4 tjedna ili pri dozama iznad 600 mg ili 8 mg/kg su ograničena.

treatment with eltrombopag should be reinitiated in accordance with dosing and administration recommendations (see section 4.2).
potrebno je ponovno započeti liječenje eltrombopagom u skladu s preporukama o doziranju i načinu primjene (vidjeti dio 4.2).

it is important to make sure an acurate dose is given each time, in order to prevent harmful effects of sialanar seen with dosing errors or overdose.
u svrhu sprječavanja nastanka nuspojava lijeka sialanar uočenih kod pogrešaka u doziranju ili predoziranja, važno je da svaki put date točnu dozu.

patients and/or parents/caregivers should be counselled to ensure an acurate dose is given each time, in order to prevent the harmful consequences of anticholinergic reactions of glycopyrronium seen with dosing errors or overdose.
bolesnici i/ili roditelji/njegovatelji trebaju dobiti savjete kako bi se zajamčilo da je svaki put primijenjena točna doza u svrhu sprječavanja nastanka štetnih posljedica antikolinergičkih reakcija na glikopironij uočenih kod pogrešaka u doziranju ili predoziranja.

the toxicity of lenvatinib was more prominent in younger rats (dosing initiated on pnd7) compared with those with dosing initiated on pnd21 and mortality and some toxicities were observed earlier in the juvenile rats at 10 mg/kg compared with adult rats administered the same dose level.
toksičnost lenvatiniba bila je izraženija u mlađih štakora (doziranje započeto 7. postnatalnog dana) u usporedbi s onima u kojih je doziranje započelo 21. postnatalnog dana i mortalitet i neke toksičnosti bile su ranije opažene u mladih štakora pri 10 mg/kg u usporedbi s odraslim štakorima kojima se primijenila ista razina doze.

in 1722 patients treated with crizotinib with either alk-positive or ros1-positive nsclc across clinical studies, the most frequent adverse reactions (≥3%) associated with dosing interruptions were neutropenia, elevated transaminases, vomiting, and nausea.
u 1722 bolesnika liječenih krizotinibom s alk-ili ros1- pozitivnim nsclc-om u kliničkim ispitivanjima, najčešće nuspojave (≥3%) povezane s prekidom terapije su bile neutropenija, povišene transaminaze, povraćanje i mučnina.